Related Experiment Video
Updated: Apr 12, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Biologically active [Pd2L4](4+) quadruply-stranded helicates: stability and cytotoxicity
Samantha M McNeill1, Dan Preston, James E M Lewis
1Department of Pharmacology and Toxicology, University of Otago, P.O. Box 913, Dunedin, New Zealand. gregory.giles@otago.ac.nz.
New palladium(II) helicates show anti-cancer promise. One complex, [Pd2(hextrz)4](BF4)4, effectively killed cancer cells by disrupting cell membranes, not DNA, offering a novel therapeutic approach.
Area of Science:
- Coordination Chemistry
- Supramolecular Chemistry
- Chemical Biology
Background:
- Metallosupramolecular systems offer unique anti-proliferative potential due to their distinct size and shape compared to small molecule drugs.
- Palladium(II) complexes are abundant but their biological activity remains largely unexplored.
- Quadruply-stranded dipalladium(II) helicates represent an underexplored class of metallosupramolecular architectures.
Purpose of the Study:
- To screen a series of [Pd2(L)4](BF4)4 quadruply-stranded, dipalladium(II) helicates for cytotoxic effects.
- To evaluate the biological activity of these helicates against various cancer cell lines and a non-malignant cell line.
- To investigate the mechanism of action for the most potent palladium(II) helicate.
Main Methods:
- Cytotoxicity screening of palladium(II) helicates against three cancer cell lines (e.g., MDA-MB-231) and one non-malignant cell line.
- Determination of half-maximal inhibitory concentration (IC50) values.
- Preliminary mechanistic studies, including assessment of DNA interaction and cell membrane disruption.
Main Results:
- The helicates displayed a range of cytotoxic activities.
- The complex [Pd2(hextrz)4](BF4)4 showed potent cytotoxicity with low micromolar IC50 values across all tested cell lines.
- This complex was significantly more active than cisplatin against platinum-drug resistant MDA-MB-231 cells and appears to act via cell membrane disruption rather than DNA interaction.
Conclusions:
- This study provides the first biological characterization of quadruply-stranded helicate architectures.
- Palladium(II) helicates, particularly [Pd2(hextrz)4](BF4)4, demonstrate significant cytotoxic potential against cancer cells.
- The findings suggest a novel mechanism of action involving cell membrane disruption, distinct from traditional metal-based drugs, and offer insights for designing future metallosupramolecular anticancer agents.
Related Concept Videos
DNA Helicases
Single-Strand DNA Binding Proteins
Inhibitors of Bacterial DNA Synthesis
Drugs that Destabilize Microtubules
Microtubule Instability
RNA Stability

